Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 6/20 | 0.48 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.45 |
| ▸ | RAMP3 | O60896 | 5/20 | 0.44 |
| ▸ | CALCR | P30988 | 5/20 | 0.44 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.44 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30420933 | 0.89 | CAPN1 (0.48) | CALCRLCAPN1RAMP3CALCROPRM1 | |
| SCHEMBL30099567 | 0.87 | CAPN1 (0.48) | CAPN1RAMP3CALCROPRM1OPRD1 | |
| SCHEMBL30420755 | 0.86 | CALCRL (0.47) | CALCRLCAPN1KEAP1OPRM1OPRD1 | |
| SCHEMBL30403555 | 0.84 | CALCRL (0.49) | CALCRLCAPN1RAMP3CALCRRAMP1 | |
| SCHEMBL30525434 | 0.84 | CALCRL (0.50) | CALCRLCAPN1RAMP1OPRM1EPHA2 | |
| SCHEMBL30085018 | 0.84 | NTSR1 (0.47) | OPRM1OPRD1 | |
| SCHEMBL30401176 | 0.83 | SLC6A2 (0.49) | CALCRLCAPN1 | |
| SCHEMBL31031512 | 0.83 | CAPN1 (0.51) | CAPN1RAMP3CALCRKEAP1OPRM1 | |
| SCHEMBL30420410 | 0.83 | KEAP1 (0.47) | CALCRLCAPN1KEAP1OPRM1OPRD1 | |
| SCHEMBL30525445 | 0.83 | CAPN1 (0.53) | CALCRLCAPN1RAMP1OPRM1EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302646-A1 | BIORESORBABLE, IMPLANTABLE DEVICE HAVING CONTROLLED DRUG DELIVERY | SCANLON JOHN JAMES (US) | 2025-10-02 | — | — | US | disclosed |
| US-12357480-B2 | Bioresorbable, implantable device having controlled drug delivery | SCANLON JOHN JAMES (US) | 2025-07-15 | — | — | US | disclosed |
| US-20240074882-A1 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION | ELIXIR MEDICAL CORPORATION (US) | 2024-03-07 | — | — | US | disclosed |
| US-20220031482-A1 | BIORESORBABLE, IMPLANTABLE DEVICE HAVING CONTROLLED DRUG DELIVERY | SCANLON JOHN JAMES (US) | 2022-02-03 | — | — | US | disclosed |